Background

The effects of desflurane, sevoflurane, and isoflurane on left ventricular-arterial coupling and mechanical efficiency were examined and compared in acutely instrumented dogs.

Methods

Twenty-four open-chest, barbiturate-anesthetized dogs were instrumented for measurement of aortic and left ventricular (LV) pressure (micromanometer-tipped catheter), dP/dtmax, and LV volume (conductance catheter). Myocardial contractility was assessed with the end-systolic pressure-volume relation (Ees) and preload recruitable stroke work (Msw) generated from a series of LV pressure-volume diagrams. Left ventricular-arterial coupling and mechanical efficiency were determined by the ratio of Ees to effective arterial elastance (Ea; the ratio of end-systolic arterial pressure to stroke volume) and the ratio of stroke work (SW) to pressure-volume area (PVA), respectively.

Results

Desflurane, sevoflurane, and isoflurane reduced heart rate, mean arterial pressure, and left ventricular systolic pressure. All three anesthetics caused similar decreases in myocardial contractility and left ventricular afterload, as indicated by reductions in Ees, Msw, and dP/dtmax and Ea, respectively. Despite causing simultaneous declines in Ees and Ea, desflurane decreased Ees/Ea (1.02 +/- 0.16 during control to 0.62 +/- 0.14 at 1.2 minimum alveolar concentration) and SW/PVA (0.51 +/- 0.04 during control to 0.43 +/- 0.05 at 1.2 minimum alveolar concentration). Similar results were observed with sevoflurane and isoflurane.

Conclusions

The present findings indicate that volatile anesthetics preserve optimum left ventricular-arterial coupling and efficiency at low anesthetic concentrations (< 0.9 minimum alveolar concentration); however, mechanical matching of energy transfer from the left ventricle to the arterial circulation degenerates at higher end-tidal concentrations. These detrimental alterations in left ventricular-arterial coupling produced by desflurane, sevoflurane, and isoflurane contribute to reductions in overall cardiac performance observed with these agents in vivo.

OPTIMUM transfer of energy from the left ventricle to the arterial circulation requires appropriate matching of these mechanical systems. Left ventricular-arterial coupling can be described in the time-dependent pressure-volume plane using a series elastic chamber model of the cardiovascular system. [1]The elastances of the contracting left ventricle (Ees) and the arterial vasculature (Ea) are determined from left ventricular end-systolic pressure-volume and end-systolic arterial pressure-stroke volume relations, respectively. [1–3]The ratio of Eesto Eadefines coupling between the left ventricle and the arterial circulation [1,2]and provides a useful technique for assessment of the actions of pharmacologic agents, including volatile anesthetics, on overall cardiovascular performance in vivo. [4,5]Analysis of the pressure-volume relation also creates a framework for the study of left ventricular mechanical efficiency defined by the ratio of stroke work (SW) to pressure-volume area (PVA). [5].

The influence of volatile anesthetics on left ventricular-arterial coupling and mechanical efficiency have not been studied completely. Desflurane, sevoflurane, and isoflurane were shown to reduce myocardial contractility concomitant with decreases in systemic vascular resistance in experimental animals [6–12]and humans. [13–15]These observations suggest that left ventricular-arterial coupling may be maintained during anesthesia because reductions in left ventricular afterload may balance declines in contractile state. This investigation compared the actions of desflurane, sevoflurane, and isoflurane on left ventricular-arterial coupling and mechanical efficiency and tested the hypothesis that these volatile anesthetics do not adversely affect the mechanical relation between the left ventricle and the arterial circulation in open-chest, barbiturate-anesthetized dogs.

All experimental procedures and protocols used in this investigation were reviewed and approved by the Animal Care and Use Committee of the Medical College of Wisconsin. All procedures conformed to the Guiding Principles in the Care and Use of Animals of the American Physiological Society and were performed in accordance with the Guide for the Care and Use of Laboratory Animals, [DHEW(DHHS) publication (NIH) no. 85–23, revised 1985].

Implantation of Instruments

Mongrel dogs (n = 24) of either sex weighing between 25 and 30 kg were fasted overnight and anesthetized with 25 mg *symbol* kg-1sodium pentobarbital and 200 mg *symbol* kg-1sodium barbital. Fluid deficits were replaced before experimentation with 500 ml 0.9% saline, which was continued at 3 ml *symbol* kg-1*symbol* h-1for the duration of each experiment. After tracheal intubation, the dogs lungs were ventilated via positive pressure with a mixture (1 l *symbol* min-1) of oxygen (90%) and air (10%). Respiratory rate and tidal volume were adjusted to maintain acid-base status (pH = 7.35–7.40) and carbon dioxide partial pressure (PCO2= 30–35 mmHg) within physiologic limits. The right femoral vein was cannulated for fluid administration. A 7F, dual micromanometer-tipped catheter (Millar Instruments, Houston, TX) was inserted through the left carotid artery and positioned across the aortic valve, with the distal transducer in the left ventricle and the proximal transducer in the ascending thoracic aorta for measurement of continuous left ventricular and arterial pressures, respectively. The peak rate of increase of left ventricular pressure (dP/dtmax) was determined by electronic differentiation of the left ventricular pressure waveform. A thoracotomy was performed in the left fifth intercostal space, and the lung was gently retracted. The pericardium was incised, and the heart was temporarily elevated from the thoracic cavity to allow access to the left ventricular apex. A 7F, eight-electrode conductance catheter with a fluid-filled lumen (Webster Labs, Baldwin Park, CA) was inserted into the left ventricular cavity through a small incision in the apex. Using a fluid-filled pressure transducer system, the conductance catheter was positioned so that the distal tip was located in the ascending thoracic aorta just distal to the aortic valve. The conductance catheter was secured firmly with a purse string suture. A hydraulic vascular occluder was positioned around the inferior vena cava for abrupt alteration of left ventricular preload. Lastly, a fluid-filled catheter was placed in the left atrial appendage for administration of hypertonic saline (20%; 5 ml), used to determine parallel conductance volume (Vp). The experimental preparation was allowed to stabilize for at least 30 min after instrumentation was completed.

Measurement of Left Ventricular Volume

The conductance technique was used to measure left ventricular volume. [16]This method was shown to accurately determine beat-to-beat changes in stroke volume (SV) and end-diastolic volume (EDV) under a variety of experimental conditions in vivo. [17–19]The multielectrode catheter was connected to a conductance module designed and constructed in our laboratory that drove a constant current (20 micro Ampere at 5 kHz) between the two outermost electrodes and measured the resultant voltage difference between each adjacent remaining electrode. Counterclockwise development of each left ventricular pressure-segmental volume diagram identified electrode-pair signals located within the left ventricle. Measured time-dependent left ventricular volume [V(t)] was determined using the equation:Equation 1where G(t)= the sum of time-dependent conductances from each intraventricular electrode pair, L = the intraelectrode distance (1.0 cm), alpha = a slope correction factor relating the measured conductance volume to actual left ventricular volume, and sigma = the blood conductivity. Parallel conductance (offset) volume (Vp) was determined using the hypertonic saline technique [16,17]and subtracted from measured volume to obtain absolute left ventricular volume during each experimental intervention. No changes in parallel conductance volume were observed during or after administration of volatile anesthetics. Blood conductivity (sigma) was determined at each intervention from a 5 ml blood sample using a cuvette that was precalibrated with solutions of known conductivity. No changes in sigma were observed during each experiment. Previous investigations have shown that alpha is approximately equal to one and remains relatively constant during a variety of physiologic or pharmacologic interventions. [19–21]End-systolic volume (ESV) and EDV were measured at maximum left ventricular elastance [22]and immediately before the onset of left ventricular isovolumic contraction, respectively. Typical hemodynamic waveforms and left ventricular pressure-volume diagrams obtained during abrupt occlusion of the inferior vena cava are depicted in Figure 1. Ejection fraction (EF) was determined using the equation: EF =(EDV -- ESV)*symbol* EDV-1. Hemodynamic data were recorded continuously on a polygraph (model 7, Grass Instruments, Quincy, MA) and simultaneously digitized by a computer interfaced with an analog to digital converter for recording and subsequent analysis of left ventricular pressure-volume diagrams.

Figure 1. Continuous left ventricular pressure, left ventricular dP/dt, left ventricular volume, and arterial blood pressure waveforms (left panel) and left ventricular pressure-volume diagrams (right panel) during inferior vena caval occlusion observed in a typical experiment. The left ventricular maximal elastances (solid dots) for each pressure-volume diagram were used to generate the slope (Ees) of the end-systolic pressure-volume relation. Effective arterial elastance (Ea) was determined by the ratio of left ventricular end-systolic pressure and stroke volume during steady-state hemodynamic conditions (see text). In the pressure-volume plane, Earepresents the magnitude of the slope connecting end-systole to end-diastole (right panel).

Figure 1. Continuous left ventricular pressure, left ventricular dP/dt, left ventricular volume, and arterial blood pressure waveforms (left panel) and left ventricular pressure-volume diagrams (right panel) during inferior vena caval occlusion observed in a typical experiment. The left ventricular maximal elastances (solid dots) for each pressure-volume diagram were used to generate the slope (Ees) of the end-systolic pressure-volume relation. Effective arterial elastance (Ea) was determined by the ratio of left ventricular end-systolic pressure and stroke volume during steady-state hemodynamic conditions (see text). In the pressure-volume plane, Earepresents the magnitude of the slope connecting end-systole to end-diastole (right panel).

Close modal

Experimental Protocol

After instrumentation had been completed, left ventricular pressure-volume diagrams used to assess myocardial contractility were obtained at end-expiration by abruptly decreasing left ventricular preload via inflation of the inferior vena caval balloon cuff occluder, resulting in an approximately 25-mmHg decline in left ventricular systolic pressure during 10–15 cardiac cycles (Figure 1). Using linear regression analysis, the end-systolic pressure (Pes) and volume (Ves) of each left ventricular pressure-volume diagram during the inferior caval occlusion were fit to the equation: Pes= Ees*symbol*(Ves- Vo), where Ees= left ventricular end-systolic elastance and Vo= the extrapolated volume intercept of the relation (Figure 2). Myocardial contractility also was evaluated with the preload recruitable stroke work relation derived from the same left ventricular pressure-volume diagrams using linear regression analysis:Equation 2where SW is stroke work (calculated as the integral of the pressure-volume diagram for each cardiac cycle) and Mswand Vsware the slope and volume intercept of the preload recruitable stroke work relation, respectively (Figure 2). [23]Effective arterial elastance (Ea) was calculated as the ratio of end-systolic arterial pressure and SV under steady-state hemodynamic conditions immediately before inferior vena caval occlusion. [1,2]Left ventricular-arterial coupling was described as the ratio of Eesand Ea. [1]The PVA (total mechanical energy) was determined at each intervention as the sum of SW and potential energy, where potential energy = 0.5 *symbol* Pes*symbol*(Ves- Vo). [24]In this framework, potential energy represents the energy expended by the left ventricle that does not contribute to ejection. The ratio of SW to PVA was used to determine the mechanical efficiency of energy transfer of PVA to externally performed SW. [25].

Figure 2. End-systolic pressure-volume (top panel) and stroke work-end-diastolic volume relations (bottom panel) before (control 1; C (1)), during 0.6, 0.9, and 1.2 minimum alveolar concentration, and after isoflurane (control 2; C2) in a typical experiment. Pesand V (es)= end-systolic pressure and volume, respectively; SW = stroke work; Ved= end-diastolic volume.

Figure 2. End-systolic pressure-volume (top panel) and stroke work-end-diastolic volume relations (bottom panel) before (control 1; C (1)), during 0.6, 0.9, and 1.2 minimum alveolar concentration, and after isoflurane (control 2; C2) in a typical experiment. Pesand V (es)= end-systolic pressure and volume, respectively; SW = stroke work; Ved= end-diastolic volume.

Close modal

Dogs were assigned to receive desflurane, sevoflurane, and isoflurane in a random manner in three separate groups of experiments. Baseline systemic hemodynamics and left ventricular pressure-volume diagrams were recorded during control conditions 30 min after the instrumentation was completed. In one group of experiments, 0.6, 0.9, and 1.2 minimum alveolar concentration (MAC)(end-tidal) desflurane was administered. The order of MAC was assigned randomly. Hemodynamics were recorded, and left ventricular pressure-volume diagrams were obtained using the techniques described above after 15 min equilibration at each dose. Desflurane was then discontinued and measurements were repeated after the anesthetic was eliminated. In two other groups of experiments, hemodynamics and left ventricular pressure-volume diagrams were recorded at the time intervals described above in dogs before, during, and after 0.6, 0.9, and 1.2 MAC sevoflurane or isoflurane. The canine MAC values for desflurane, sevoflurane, and isoflurane used in this investigation were 7.20%, 2.36%, and 1.28%, respectively. End-tidal concentrations of volatile anesthetics were measured at the tip of the endotracheal tube by an infrared gas analyzer (Datex Capnomac, Helsinki, Finland) that was calibrated with known standards before and during experimentation. At the end of each experiment, the heart was electrically fibrillated, and the positions of the fluid-filled, conductance, and micromanometer-tipped catheters were confirmed.

Statistical Analysis

Statistical analysis of the data within and between groups before and during the administration of desflurane, sevoflurane, and isoflurane was performed by multiple analysis of variance with repeated measures, followed by use of Student's t test, with Bonferroni's adjustment for multiplicity. Changes were considered statistically significant when the probability (P) value was < 0.05. All data are expressed as mean +/-SEM.

Twenty-four dogs were used to provide 21 complete experiments. Three dogs were excluded from analysis because of instrument failure. Desflurane caused significant (P < 0.05) decreases in heart rate, mean arterial pressure, and left ventricular systolic pressure (Table 1). Left ventricular end-diastolic pressure, EDV, and ESV were unchanged by desflurane. A decrease in SV occurred at 1.2 MAC. Dose-related reductions in the slopes of the end-systolic pressure-volume (Ees; 3.3 +/-0.5 during control to 1.2+/-0.2 mmHg *symbol* ml-1at 1.2 MAC) and the preload recruitable SW relation (Msw; 57 +/-6 during control to 30+/-4 mmHg at 1.2 MAC) were produced by desflurane, indicating that a direct depression of myocardial contractility occurred. The volume intercepts (Voand Vsw, respectively) of these relations remained unchanged. Concomitant reductions in dP/dtmaxand EF were observed. Desflurane also produced dose-related decreases in Ea(3.3+/-0.3 during control to 2.1+/-0.2 mmHg *symbol* ml-1at 1.2 MAC). Despite simultaneous declines in Eesand Ea, the ratio of these variables (Ees/Ea) decreased at the highest concentration of desflurane (1.02+/-0.16 during control to 0.62+/-0.14 at 1.2 MAC, Figure 3), indicating that this volatile anesthetic caused an alteration in mechanical coupling of the left ventricle to the arterial circulation. In addition, desflurane also decreased SW/PVA (0.51 +/-0.04 during control to 0.43+/-0.05 at 1.2 MAC;Figure 3), consistent with a decline in the conversion of total left ventricular energy to external SW. Discontinuation of desflurane caused hemodynamics, contractility (Eesand Msw), and afterload (Ea) to return to baseline values.

Table 1. Hemodynamic Effects of Desflurane

Table 1. Hemodynamic Effects of Desflurane
Table 1. Hemodynamic Effects of Desflurane

Figure 3. Histograms depicting left ventricular-arterial coupling (Ees/Ea; top panel) and mechanical efficiency (stroke work [SW]/pressure-volume area [PVA]; bottom panel) before (control 1; C1), during 0.6, 0.9, and 1.2 minimum alveolar concentration, and after desflurane (control 2; C2).aSignificantly (P < 0.05) different from C1;bSignificantly (P < 0.05) different from 0.6 minimum alveolar concentration desflurane.

Figure 3. Histograms depicting left ventricular-arterial coupling (Ees/Ea; top panel) and mechanical efficiency (stroke work [SW]/pressure-volume area [PVA]; bottom panel) before (control 1; C1), during 0.6, 0.9, and 1.2 minimum alveolar concentration, and after desflurane (control 2; C2).aSignificantly (P < 0.05) different from C1;bSignificantly (P < 0.05) different from 0.6 minimum alveolar concentration desflurane.

Close modal

Sevoflurane and isoflurane caused hemodynamic and mechanical effects very similar to those produced by desflurane (Table 2and Table 3, respectively). Sevoflurane and isoflurane decreased heart rate, mean arterial pressure, and left ventricular systolic pressures. No changes in left ventricular end-diastolic pressure, EDV, and ESV were observed. In contrast to the findings with desflurane and isoflurane, SV remained unchanged during sevoflurane anesthesia. Sevoflurane and isoflurane caused dose-related depression of contractile state (Eesand Msw) and reductions in Ea(Table 2and Table 3). Depression of myocardial contractility and decreases in Eaobserved in dogs receiving sevoflurane and isoflurane were similar to those produced by desflurane. Sevoflurane (Figure 4) and isoflurane (Figure 5) caused declines in E (es)/Ea(e.g., 1.07+/-0.20 during control to 0.59 +/-0.13 at 1.2 MAC sevoflurane;Figure 4) and SW/PVA (e.g., 0.54 +/-0.06 during control to 0.42+/-0.05 at 1.2 MAC sevoflurane;Figure 4), indicating that these volatile anesthetics impair normal left ventricular-arterial coupling and mechanical efficiency. Sevoflurane- and isoflurane-induced alterations in coupling and efficiency variables were similar in magnitude to those observed during desflurane anesthesia. Hemodynamics and left ventricular mechanical properties returned to control values after sevoflurane and isoflurane was discontinued.

Table 2. Hemodynamic Effects of Sevoflurane

Table 2. Hemodynamic Effects of Sevoflurane
Table 2. Hemodynamic Effects of Sevoflurane

Table 3. Hemodynamic Effects of Isoflurane

Table 3. Hemodynamic Effects of Isoflurane
Table 3. Hemodynamic Effects of Isoflurane

Figure 4. Histograms depicting left ventricular-arterial coupling (Ees/Ea; top panel) and mechanical efficiency (stroke work [SW]/pressure-volume area [PVA]; bottom panel) before (control 1; C1), during 0.6, 0.9, and 1.2 minimum alveolar concentration, and after sevoflurane (control 2; C2).aSignificantly (P < 0.05) different from C1;bSignificantly (P < 0.05) different from 0.9 minimum alveolar concentration sevoflurane;cSignificantly (P < 0.05) different from 1.2 minimum alveolar concentration sevoflurane.

Figure 4. Histograms depicting left ventricular-arterial coupling (Ees/Ea; top panel) and mechanical efficiency (stroke work [SW]/pressure-volume area [PVA]; bottom panel) before (control 1; C1), during 0.6, 0.9, and 1.2 minimum alveolar concentration, and after sevoflurane (control 2; C2).aSignificantly (P < 0.05) different from C1;bSignificantly (P < 0.05) different from 0.9 minimum alveolar concentration sevoflurane;cSignificantly (P < 0.05) different from 1.2 minimum alveolar concentration sevoflurane.

Close modal

Figure 5. Histograms depicting left ventricular-arterial coupling (Ees/Ea; top panel) and mechanical efficiency (stroke work [SW]/pressure-volume area [PVA]; bottom panel) before (control 1; C1), during 0.6, 0.9, and 1.2 minimum alveolar concentration, and after isoflurane (control 2; C2).aSignificantly (P < 0.05) different from C1; Significantly (P < 0.05) different from 0.9 minimum alveolar concentration isoflurane;cSignificantly (P < 0.05) different from 1.2 minimum alveolar concentration isoflurane.

Figure 5. Histograms depicting left ventricular-arterial coupling (Ees/Ea; top panel) and mechanical efficiency (stroke work [SW]/pressure-volume area [PVA]; bottom panel) before (control 1; C1), during 0.6, 0.9, and 1.2 minimum alveolar concentration, and after isoflurane (control 2; C2).aSignificantly (P < 0.05) different from C1; Significantly (P < 0.05) different from 0.9 minimum alveolar concentration isoflurane;cSignificantly (P < 0.05) different from 1.2 minimum alveolar concentration isoflurane.

Close modal

The current results indicate that desflurane, sevoflurane, and isoflurane produce similar reductions in myocardial contractility, as evaluated by Eesand Mswderived from left ventricular pressure-volume diagrams generated using the conductance catheter technique to invasively measure continuous left ventricular volume. The current findings confirm and extend the results of previous investigations from our laboratory [7,8,26]in which regional preload recruitable SW derived using sonomicrometry was used as a relatively heart rate- and load-independent index of contractile state in chronically instrumented dogs. The negative inotropic effects of volatile anesthetics were accompanied by reductions in Ea, confirming the findings of several previous investigations that indicate that desflurane, sevoflurane, and isoflurane decrease resistance to left ventricular outflow. [9–14,27]These observations suggest that mechanical matching between the left ventricle and the arterial vasculature may be preserved during anesthesia because reductions in left ventricular afterload may balance declines in contractile state. This hypothesis was tested using a series elastic chamber model of left ventricular-arterial coupling quantified with the ratio of left ventricular end-systolic elastance (Ees) to effective arterial elastance (Ea). [1,2]Left ventricular SW has been shown to be maximized when Eesequals Eain both isolated and intact hearts. [2–4].

The current investigation is the first to examine the effects of volatile anesthetics on left ventricular-arterial coupling and mechanical efficiency derived from a series of differentially loaded left ventricular pressure-volume diagrams in vivo. The results indicate that desflurane, sevoflurane, and isoflurane maintain nearly optimum left ventricular-arterial coupling and mechanical efficiency at low concentrations (< 0.9 MAC), however, these vasodilating negative inotropes adversely affect mechanical matching between the left ventricle and arterial circulation and reduce the transfer of total left ventricular energy to external SW at higher anesthetic concentrations.

Decreases in Eesobserved with desflurane, sevoflurane, and isoflurane occurred in a dose-dependent manner in the presence of the basal barbiturate anesthetic. In contrast, relatively large decreases in Eawere observed at the 0.6 MAC concentration of the volatile anesthetics that were not further reduced at the 0.9 and 1.2 MAC doses. These findings suggest that a decrease in peripheral sympathetic nervous system tone may have accompanied the low dose of the volatile agents with little further effect and higher doses.

A single previous study compared the influence of isoflurane and halothane on left ventricular-arterial coupling using a single-beat method to determine Eesand Vowithout altering the loading conditions of the left ventricle in pentobarbital and alpha-chloralose-anesthetized, acutely instrumented dogs. [28]The authors demonstrated that low concentrations of halothane (1 MAC), but not isoflurane, reduced Ees/Ea, consistent with depression of mechanical coupling between the left ventricle and the arterial circulation. [28]However, isoflurane decreased Ees/Eaat 2 MAC, suggesting that the vasodilating effects of this volatile agent were unable to compensate adequately for relatively greater declines in contractility. Although single-beat derivation of Eeswas validated previously, [29]interpretation of the results of Kawasaki et al. [28]requires qualification because of several major potential limitations with this method. Single-beat analysis of left ventricular end-systolic pressure-volume relations assumes symmetric left ventricular pressure rise and fall and requires extrapolation of peak isovolumic-developed pressure from the left ventricular pressure waveform of an ejecting beat. [29,30]The single-beat estimation of Eesassumes that Voremains constant during inotropic interventions, but Vowas shown to be altered significantly by changes in ventricular loading conditions or contractile state. [31]In addition, assumptions of complete linearity and total load-independence of the end-systolic pressure-volume relation may represent inappropriate simplifications because previous studies demonstrated that some degree of curvilinearity and afterload dependence is inherent to the relation. [32–34]Lastly, a recent investigation showed that single-beat estimation of Eesalso may be relatively insensitive to changes in inotropic state when compared with Eesderived invasively from left ventricular pressure-volume diagrams. [30]Despite these potential limitations, the current results support the findings of Kawasaki et al. [28]and indicate that isoflurane does not adversely affect left ventricular-arterial coupling at anesthetic concentrations < 0.9 MAC.

The current results should be interpreted within the constraints of several possible shortcomings. Our results may differ from those obtained in conscious, chronically instrumented dogs because of the cardiovascular depression associated with barbiturate anesthesia and acute surgical instrumentation. The inherent negative inotropic effect of the barbiturate anesthetic may have contributed to a more profound depression of contractility with desflurane, sevoflurane, and isoflurane in the current study than was previously observed in chronically instrumented dogs. [6–10,35]In addition, lack of a conscious control state may make difficult a comparison of the current results to previous studies that examined the mechanical effects of volatile anesthetics. The possibility of drug interaction between the basal barbiturate anesthetics and volatile agents used in this investigation also cannot be excluded completely from the analysis. Nevertheless, the value of Ees/Eaobserved under control conditions before and after administration of volatile anesthetics was similar to that observed in conscious dogs. [4]Previous studies demonstrated that Ees, [33,36]but not Msw, [23,37]may be sensitive to acute alterations in left ventricular afterload. Therefore, reductions in Eaduring desflurane, sevoflurane, and isoflurane anesthesia may have partially attenuated the decreases in Eesproduced by these agents. However, decreases in the magnitude of Eesand Mswin response to the volatile anesthetics were appropriately matched, indicating that reductions in afterload probably did not adversely affect evaluation of contractility using Ees. The slope of the end-systolic pressure-volume relation also was reported to be curvilinear over a wide range of pressures. [32,34,38]However, over the relatively narrow range of pressures observed in the current investigation, the end-systolic pressure-volume relation was shown to be essentially linear. [38]A previous study [19]demonstrated that E (es) and Vowere consistently underestimated with the conductance catheter measurement of left ventricular volume. However, alterations E (es) in response to interventions that alter contractile state (e.g., autonomic nervous system blockade and dobutamine) were appropriately detected and quantified with the conductance technique, as compared with three-dimensional sonomicrometry. [19]Therefore, it is likely that decreases in myocardial contractility produced by desflurane, sevoflurane, and isoflurane were quantified accurately, with Eescalculated from conductance catheter-derived left ventricular volume.

Effective arterial elastance is a composite coupling variable influenced by systemic vascular resistance and total arterial compliance. However, Eacannot be used to quantify alterations in left ventricular afterload, because this parameter ignores characteristic aortic impedance, an important high frequency component of the arterial vascular behavior. Left ventricular afterload is a complex description of frequency-dependent arterial mechanical properties that be strictly quantified only with aortic input impedance. [27,39]Nevertheless, E (a) provides a useful framework for the analysis of left ventricular-arterial coupling relations in vivo. [1,2]The calculation of SV required for the determination of Eausing the conductance technique also was validated previously, under a variety of experimental conditions. [16,17]We assumed that the slope correction factor (alpha) used in the determination of left ventricular volume was equal to 1. [40,41]The value of alpha may vary, to some degree, between dogs because of differences in left ventricular geometry. However, this potential source of bias was probably eliminated, because dogs were assigned to receive desflurane, sevoflurane, and isoflurane in a random manner. Recent evidence also suggests that alpha also may vary with the changes in left ventricular volume that occur during the cardiac cycle or as a result of rapid changes in ventricular volume (as may occur during vena caval occlusion). [42–44]Such volume-dependent alterations in alpha theoretically may contribute to a relative underestimation of SV and EDV. [43]The value of Vpmay change during large alterations in left ventricular volume, [19,20]again introducing possible error in the measurement of absolute left ventricular volume during experimental interventions or abrupt alteration of preload. However, potential errors in alpha and Vpwere probably minimized in this investigation because left ventricular arterial coupling and mechanical efficiency were described using ratios (Ees/Eaand SW/PVA) of volume-derived variables. Despite these potential limitations, the conductance method used to determine left ventricular volume in the current study has been widely established as a valid technique for the determination of beat-to-beat changes in SV and EDV under a wide variety of experimental conditions in vivo. [17–19,45].

In summary, the current results demonstrate that desflurane, sevoflurane, and isoflurane decrease myocardial contractility and reduce left ventricular afterload in barbiturate-anesthetized, open-chest dogs. These vasodilating negative inotropes maintain optimum left ventricular-arterial coupling and mechanical efficiency, as evaluated by Ees/Eaand SW/PVA, respectively, at low anesthetic concentrations (< 0.9 MAC). However, mechanical matching between the left ventricle and the arterial vasculature and efficiency of total left ventricular energy transfer to external SW degenerated at higher anesthetic concentrations, indicating that anesthetic-induced reductions in left ventricular contractility are not appropriately balanced by simultaneous declines in afterload. These adverse alterations in left ventricular-arterial coupling produced by desflurane, sevoflurane, and isoflurane contribute to reductions in overall cardiac performance observed with these agents in vivo.

The authors thank Rich Rys for the design and construction of the conductance module and Dave Schwabe for technical assistance.

1.
Sunagawa K, Maughan WL, Burkhoff D, Sagawa K: Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983; 245:H773-80.
2.
Sunagawa K, Maughan WL, Sagawa K: Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 1985; 56:586-95.
3.
Burkhoff D, Sagawa K: Ventricular efficiency predicted by an analytical model. Am J Physiol 1986; 250:R1021-7.
4.
Little WC, Cheng C-P: Left ventricular-arterial coupling in conscious dogs. Am J Physiol 1991; 261:H70-6.
5.
Starling MR: Left ventricular-arterial coupling relations in the normal human heart. Am Heart J 1993; 125:1659-66.
6.
Pagel PS, Kampine JP, Schmeling WT, Warltier DC: Comparison of end-systolic pressure-length relations and preload recruitable stroke work as indices of myocardial contractility in the conscious and anesthetized, chronically instrumented dog. ANESTHESIOLOGY 1990; 73:278-90.
7.
Pagel PS, Kampine JP, Schmeling WT, Warltier DC: Influence of volatile anesthetics on myocardial contractility in vivo: Desflurane versus isoflurane. ANESTHESIOLOGY 1991; 74:900-7.
8.
Harkin CP, Pagel PS, Kersten JR, Hettrick DA, Warltier DC: Direct negative inotropic and lusitropic effects of sevoflurane. ANESTHESIOLOGY 1994; 81:156-67.
9.
Merin RG: Are the myocardial functional and metabolic effects of isoflurane really different from those of halothane and enflurane? ANESTHESIOLOGY 1981; 55:398-408.
10.
Merin RG, Bernard JM, Doursout MF, Cohen M, Chelly JE: Comparison of the effects of isoflurane and desflurane on cardiovascular dynamics and regional blood flow in the chronically instrumented dog. ANESTHESIOLOGY 1991; 74:568-74.
11.
Weiskopf RB, Holmes MA, Eger EI, II, Johnson BH, Rampil IJ, Brown JG: Cardiovascular effects of 1653 in swine. ANESTHESIOLOGY 1988; 69:303-9.
12.
Bernard JM, Wouters PF, Doursout MF, Florence B, Chelly JE, Merin RG: Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in chronically instrumented dogs. ANESTHESIOLOGY 1990; 72:659-62.
13.
Stevens WC, Cromwell TH, Halsey MJ, Eger EI, II, Shakespeare TF, Bahlman SH: The cardiovascular effects of a new inhalation anesthetic, Forane, in human volunteers at constant arterial carbon dioxide tension. ANESTHESIOLOGY 1971; 35:8-16.
14.
Weiskopf RB, Cahalan MK, Eger EI, II, Yasuda N, Rampil IJ, Ionescu P, Lockhart SH, Johnson BH, Freire B, Kelley S: Cardiovascular actions of desflurane in normocarbic volunteers. Anesth Analg 1991; 73:143-56.
15.
Malan TP, DiNardo JA, Isner RJ, Frink EJ, Goldberg M, Fenster PE, Brown EA, Depa R, Hammond LC, Mata H: Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers. ANESTHESIOLOGY 1995; 83:918-28.
16.
Baan J, Jong TT, Kerkhof PLM, Moene RJ, Van Dijk AD, Van der Velde ET, Koops J: Continuous stroke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter. Cardiovasc Res 1981; 15:328-34.
17.
Baan J, Van der Velde ET, De Bruin HG, Smeenk GJ, Koops J, van Dijk AD, Temmerman D, Senden J, Buis B: Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 1984; 70:812-23.
18.
Kass DA, Yamazaki T, Burkhoff D, Maughan WL, Sagawa K: Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation 1986; 73:586-95.
19.
Applegate RJ, Cheng C-P, Little WC: Simultaneous conductance catheter and dimension assessment of left ventricle volume in the intact animal. Circulation 1990; 81:638-48.
20.
Boltwood CM Jr, Appleyard RF, Glantz SA: Left ventricular volume measurement by conductance catheter in intact dogs. Parallel conductance volume depends on left ventricular size. Circulation. 1989; 80:1360-77.
21.
Szwarc RS, Mickleborough LL, Mizuno S, Wilson GJ, Liu P, Mohamed S: Conductance catheter measurements of left ventricular volume in the intact dog: Parallel conductance is independent of left ventricular size. Cardiovasc Res 1994; 28:252-8.
22.
Suga H, Sagawa K: Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 1974; 35:117-26.
23.
Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW, Olsen CO, Tyson GS, Sabiston DC Jr, Rankin JS: Linearity of the Frank-Starling relationship in the intact heart: The concept of preload recruitable stroke work. Circulation 1985; 71:994-1009.
24.
Suga H, Hayashi T, Shirahata M: Ventricular systolic pressure-volume area as a predictor of cardiac oxygen consumption. Am J Physiol 1981; 240:H39-44.
25.
Nozawa T, Yasumura Y, Futaki S, Tanaka N, Venishi M, Suga H: Efficiency of energy transfer from pressure-volume area to external mechanical work increases with contractile state and decreases with afterload in the left ventricle of the anesthetized closed-chest dog. Circulation 1988; 77:1116-24.
26.
Pagel PS, Nijhawan N, Warltier DC: Quantitation of volatile anesthetic-induced depression of myocardial contractility using a single beat index derived from maximal ventricular power. J Cardiothorac Vasc Anesth 1993; 7:688-95.
27.
Hettrick DA, Pagel PS, Warltier DC: Differential effects of isoflurane and halothane on aortic input impedance quantified using a three element Windkessel model. ANESTHESIOLOGY 1995; 83:361-73.
28.
Kawasaki T, Hoka S, Okamoto H, Okuyama T, Takahashi S: The difference of isoflurane and halothane in ventriculoarterial coupling in dogs. Anesth Analg 1994; 79:681-6.
29.
Takeuchi M, Igarashi Y, Tomimoto S, Odake M, Hayashi T, Tsukamoto T, Hata K, Takaoka H, Fukuzaki H: Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation 1991; 83:202-12.
30.
Iwase T, Tomita T, Miki S, Nagai K, Murakami T: Slope of the end-systolic pressure-volume relation derived from single beat analysis is not always sensitive to positive inotropic stimuli in humans. Am J Cardiol 1992; 69:1345-53.
31.
Crottogini AJ, Willshaw P, Barra JG, Armentano R, Cabrera Fischer EI, Pichel RH: Inconsistency of the slope and the volume intercept of the end-systolic pressure-volume relationship as individual indexes of inotropic state in conscious dogs: Presentation of an index combining both variables. Circulation 1987; 76:1115-26.
32.
Kass DA, Beyar R, Lankford E, Heard M, Maughan WL, Sagawa K: Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations. Circulation 1989; 79:167-78.
33.
Van der Velde ET, Burkhoff D, Steendijk P, Karsdon J, Sagawa K, Baan J: Nonlinearity and load sensitivity of end-systolic pressure-volume relation of canine left ventricle in vivo. Circulation 1991; 83:315-27.
34.
Burkhoff D, Sugiura S, Yue DT, Sagawa K: Contractility-dependent curvilinearity of end-systolic pressure-volume relations. Am J Physiol 1987; 252:H1218-27.
35.
Pagel PS, Kampine JP, Schmeling WT, Warltier DC: Comparison of the systemic and coronary hemodynamic actions of desflurane, isoflurane, halothane, and enflurane in the chronically instrumented dog. ANESTHESIOLOGY 1991; 74:539-51.
36.
Freeman GL, Little WC, O'Rourke RA: The effect of vasoactive agents on the left ventricular end-systolic pressure-volume relation in closed chest dogs. Circulation 1986; 74:1107-13.
37.
Little WC, Cheng CP, Mumma M, Igarashi Y, Vinten-Johansen J, Johnston WE: Comparison of measures of left ventricular contractile performance derived from pressure-volume loops in conscious dogs. Circulation 1989; 80:1378-87.
38.
Little WC, Cheng CP, Peterson T, Vinten-Johansen J: Response of the left ventricular end-systolic pressure-volume relation in conscious dogs to a wide range of contractile states. Circulation 1988; 78:736-45.
39.
Milnor WR: Arterial impedance as ventricular afterload. Circ Res 1975; 36:565-70.
40.
Burkhoff D: The conductance method of left ventricular volume estimation. Methodologic limitations put into perspective. Circulation 1990; 81:703-6.
41.
Kass DA, Grayson R, Marino P: Pressure-volume analysis as a method for quantifying simultaneous drug (amrinone) effects on arterial load and contractile state in vivo. J Am Coll Cardiol 1990; 16:726-32.
42.
Steendijk P, Van der Velde ET, Baan J: Left ventricular stroke volume by single and dual excitation of conductance catheter in dogs. Am J Physiol 1993; 264:H2198-207.
43.
Szwarc RS, Laurent D, Allegrini PR, Ball HA: Conductance catheter measurement of left ventricular volume: Evidence for non-linearity within the cardiac cycle. Am J Physiol 1995; 268:H1490-8.
44.
Stamato TM, Szwarc RS, Benson LN: Measurement of right ventricular volume by conductance catheter in close-chest pigs. Am J Physiol 1995; 269:H869-76.
45.
Applegate RJ, Little WC: Alteration of autonomic influence on left ventricular contractility by epicardial superfusion with hexamethonium and procaine. Cardiovasc Res 1994; 28:1042-8.